A broad-spectrum antiviral targeting entry of enveloped viruses
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
We describe an antiviral small molecule, LJ001, effective against numerous enveloped viruses including Influenza A, filoviruses, poxviruses, arenaviruses, bunyaviruses, paramyxoviruses, flaviviruses, and HIV-1. In sharp contrast, the compound had no effect on the infection of nonenveloped viruses. In vitro and in vivo assays showed no overt toxicity. LJ001 specifically intercalated into viral membranes, irreversibly inactivated virions while leaving functionally intact envelope proteins, and inhibited viral entry at a step after virus binding but before virus–cell fusion. LJ001 pretreatment also prevented virus-induced mortality from Ebola and Rift Valley fever viruses. Structure–activity relationship analyses of LJ001, a rhodanine derivative, implicated both the polar and nonpolar ends of LJ001 in its antiviral activity. LJ001 specifically inhibited virus–cell but not cell–cell fusion, and further studies with lipid biosynthesis inhibitors indicated that LJ001 exploits the therapeutic window that exists between static viral membranes and biogenic cellular membranes with reparative capacity. In sum, our data reveal a class of broad-spectrum antivirals effective against enveloped viruses that target the viral lipid membrane and compromises its ability to mediate virus–cell fusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Membrane curvature and mechanisms of dynamic cell membrane remodelling
McMahon, H. T., & Gallop, J. L. (2005) · Nature · doi:10.1038/nature04396 · Cited by 2,163
Endocytosis and the recycling of plasma membrane.
Steinman, R. M., Mellman, I. S., Muller, W. A., & Cohn, Z. A. (1983) · The Journal of cell biology · doi:10.1083/jcb.96.1.1 · Cited by 1,450
Sen, G. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.255 · Cited by 968
Functional classification of interferon-stimulated genes identified using microarrays
de Veer, M. J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J. M., Silverman, R. H., & Williams, B. R. G. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.912 · Cited by 900
Protein-Lipid Interplay in Fusion and Fission of Biological Membranes
Chernomordik, L. V., & Kozlov, M. M. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161504 · Cited by 782
EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus
Negrete, O. A., Levroney, E. L., Aguilar, H. C., Bertolotti-Ciarlet, A., Nazarian, R., Tajyar, S., & Lee, B. (2005) · Nature · doi:10.1038/nature03838 · Cited by 570
Self-citationPlasma Membrane Disruption: Repair, Prevention, Adaptation
McNeil, P. L., & Steinhardt, R. A. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.111301.140101 · Cited by 491
Lipid traffic: floppy drives and a superhighway
Holthuis, J. C. M., & Levine, T. P. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1591 · Cited by 490
Al-Nasiry, S., Geusens, N., Hanssens, M., Luyten, C., & Pijnenborg, R. (2007) · Human Reproduction · doi:10.1093/humrep/dem011 · Cited by 486
EUKARYOTIC PHOSPHOLIPID BIOSYNTHESIS
Kent, C. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.001531 · Cited by 381
Two Key Residues in EphrinB3 Are Critical for Its Use as an Alternative Receptor for Nipah Virus
Negrete, O. A., Wolf, M. C., Aguilar, H. C., Enterlein, S., Wang, W., Mühlberger, E., Su, S. V., Bertolotti-Ciarlet, A., Flick, R., & Lee, B. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020007 · Cited by 322
Self-citationChernomordik, L. V., Zimmerberg, J., & Kozlov, M. M. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200607083 · Cited by 218
Koval, M., & Pagano, R. E. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.6.2169 · Cited by 217
Mini ReviewHuman Interferons Alpha, Beta and Omega
Bekisz, J., Schmeisser, H., Hernandez, J., Goldman, N. D., & Zoon, K. C. (2004) · Growth Factors · doi:10.1080/08977190400000833 · Cited by 194
Coping with the inevitable: how cells repair a torn surface membrane
McNeil, P. L., & Terasaki, M. (2001) · Nature Cell Biology · doi:10.1038/35074652 · Cited by 187
Cell Cycle Status Affects Coxsackievirus Replication, Persistence, and Reactivation In Vitro
Feuer, R., Mena, I., Pagarigan, R., Slifka, M. K., & Whitton, J. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4430-4440.2002 · Cited by 183
Sleight, R. G., & Pagano, R. E. (1984) · The Journal of cell biology · doi:10.1083/jcb.99.2.742 · Cited by 168
Levroney, E. L., Aguilar, H. C., Fulcher, J. A., Kohatsu, L., Pace, K. E., Pang, M., Gurney, K. B., Baum, L. G., & Lee, B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.413 · Cited by 164
Self-citationMechanisms of Action of Ribavirin in Antiviral Therapies
Tam, R. C., Lau, J. Y. N., & Hong, Z. (2001) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020101200501 · Cited by 142
Negrete, O. A., Chu, D., Aguilar, H. C., & Lee, B. (2007) · Journal of Virology · doi:10.1128/jvi.00999-07 · Cited by 115
Self-citationThe role of transmembrane domains in membrane fusion
Langosch, D., Hofmann, M., & Ungermann, C. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6439-x · Cited by 102
Shangguan, T., Alford, D. R., & Bentz, J. (1996) · Biochemistry · doi:10.1021/bi9526903 · Cited by 99
Pleiotropic mechanisms of ribavirin antiviral activities
Hong, Z., & Cameron, C. E. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8171-5_2 · Cited by 80
Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus
Bobardt, M. D., Cheng, G., de Witte, L. D., Selvarajah, S., Chatterji, U., Sanders-Beer, B. E., Geijtenbeek, T. B. H., Chisari, F. V., & Gallay, P. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801388105 · Cited by 79
Effects of Spontaneous Bilayer Curvature on Influenza Virus–mediated Fusion Pores
Razinkov, V. I., Melikyan, G. B., Epand, R. M., Epand, R. F., & Cohen, F. S. (1998) · The Journal of General Physiology · doi:10.1085/jgp.112.4.409 · Cited by 69
Langosch, D., Brosig, B., & Pipkorn, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102579200 · Cited by 49
Rho GTPase activity modulates paramyxovirus fusion protein-mediated cell–cell fusion
Schowalter, R. M., Wurth, M. A., Aguilar, H. C., Lee, B., Moncman, C. L., McCann, R. O., & Dutch, R. (2006) · Virology · doi:10.1016/j.virol.2006.01.033 · Cited by 35
Self-citationWolf, M. C., Wang, Y., Freiberg, A. N., Aguilar, H. C., Holbrook, M. R., & Lee, B. (2009) · Virology Journal · doi:10.1186/1743-422x-6-119 · Cited by 32
Self-citationMartin, I., & Ruysschaert, J. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00171-4 · Cited by 31
Surface wound healing: a new, general function of eukaryotic cells
Meldolesi, J. (2003) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2003.tb00220.x · Cited by 24
Cited by
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Liu, S.-Y., Aliyari, R., Chikere, K., Li, G., Marsden, M. D., Smith, J. K., Pernet, O., Guo, H., Nusbaum, R., Zack, J. A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.11.005 · Cited by 678
Self-citationRecent discovery and development of inhibitors targeting coronaviruses
Pillaiyar, T., Meenakshisundaram, S., & Manickam, M. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.01.015 · Cited by 361
Kim, Y., Lovell, S., Tiew, K.-C., Mandadapu, S. R., Alliston, K. R., Battaile, K. P., Groutas, W. C., & Chang, K.-O. (2012) · Journal of Virology · doi:10.1128/jvi.01348-12 · Cited by 360
The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target
Abu-Farha, M., Thanaraj, T. A., Qaddoumi, M. G., Hashem, A., Abubaker, J., & Al-Mulla, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103544 · Cited by 300
Metadata
- Authors
- Wolf, M. C., Freiberg, A. N., Zhang, T., Akyol-Ataman, Z., Grock, A., Hong, P. W., Li, J., Watson, N. F., Fang, A. Q., Aguilar, H. C., Porotto, M., Honko, A. N., Damoiseaux, R., Miller, J. P., Woodson, S. E., Chantasirivisal, S., Fontanes, V., Negrete, O. A., Krogstad, P., Dasgupta, A., Moscona, A., Hensley, L. E., Whelan, S. P., Faull, K. F., Holbrook, M. R., Jung, M. E., & Lee, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-01-28
- Volume
- 107
- Issue
- 7
- Pages
- 3157-3162
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1975409603
- Cited by
- 254
- References
- 30
- FWCI
- 15.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.